Now showing items 21-28 of 28

    • Deborggraeve, Stijn; Coronado, Ximena; Solari Illescas, Aldo; Zulantay Alfaro, Inés; Apt Baruch, Werner; Mertens, Pascal; Laurent, Thierry; Leclipteux, Thierry; Stessens, Tim; Dujardin, Jean Claude; Herdewijn, Piet; Büscher, Philippe (2009)
      Background: PCR has evolved into one of the most promising tools for T. cruzi detection in the diagnosis and control of Chagas disease. However, general use of the technique is hampered by its complexity and the lack of ...
    • Miguel De Pablos, Luis; Diaz Lozano, Isabel María; Jercic, María Isabel; Quinzada, Markela; Giménez, María José; Calabuig, Eva; Espino, Ana Margarita; Gabriel Schijman, Alejandro; Zulantay Alfaro, Inés; Apt Baruch, Werner; Osuna, Antonio (Nature Publishing Group, 2016)
      Trypanosoma cruzi is the etiological agent of Chagas disease, a neglected and emerging tropical disease, endemic to South America and present in non-endemic regions due to human migration. The MASP multigene family is ...
    • Ortiz, Sylvia; Zulantay Alfaro, Inés; Apt Baruch, Werner; Saavedra, Miguel; Solari Illescas, Aldo (Elsevier Ireland Ltd, 2015)
      © 2014 Elsevier Ireland Ltd. The etiologic agent of Chagas disease is Trypanosoma cruzi, a protozoan whose life cycle involves obligatory passage through vertebrate and invertebrate hosts in a series of stages. The aim of ...
    • Apt Baruch, Werner (Elsevier, 2017)
      Although Chagas disease has existed for at least 9000 years, its treatment is recent: the internationally accepted drugs nifurtimox and benznidazole date from the 1970s. Both drugs are effective in acute cases, in congenital ...
    • Apt Baruch, Werner; Arribada, Arturo; Zulantay Alfaro, Inés; Rodríguez Borges, Jorge; Saavedra, Miguel; Muñoz, Andrea (Oxford University Press, 2013)
      Objectives: To evaluate cases of chronic Chagas’ disease for the long-term effects of treatment with itraconazole on Trypanosoma cruzi infections and the regression or development of ECG abnormalities. Methods: In March ...
    • Weinberger, Katherine; Collazo, Norberto; Aguillón Gutiérrez, Juan Carlos; Molina, Mariá Carmen; Rosas, Carlos; Penã, Jaime; Pizarro, Javier; Maldonado, Ismael; Cattan Ayala, Pedro; Apt Baruch, Werner; Ferreira, Arturo (American Society of Tropical Medicine and Hygiene, 2017)
      © 2017 by The American Society of Tropical Medicine and Hygiene.Triatoma infestans is an important hematophagous vector of Chagas disease, a neglected chronic illness affecting approximately 6 million people in Latin ...
    • Coronado, Ximena; Zulantay Alfaro, Inés; Albrecht, Helena; Rozas, Marlene; Apt Baruch, Werner; Ortiz Zúñiga, Sylvia; Rodríguez Borges, Jorge; Sánchez, Gittith; Solari Illescas, Aldo (AMER SOC TROP MED & HYGIENE, 2006-06)
      To identify Trypanosoma cruzi clones from chronically infected individuals, they were transferred to triatomines by the xenodiagnosis test (XD) with Triatoma infestans. Polymerase chain reaction (PCR) and hybridization ...
    • Canals Lambarri, Mauricio; Yáñez González, Christian Ariel; Canals, Lucía; Canals Cifuentes, Andrea; Cáceres, Dante; Alvarado, Sergio A.; Cattan Ayala, Pedro; Saavedra, Miguel; Zulantay Alfaro, Inés; Apt Baruch, Werner (Sociedad Chilena de Infectologia, 2017)
      ©, 2017 Sociedad Chilena de Infectologia. All rights reserved.Chagas disease remains highly prevalent in Chile, especially between the regions of Arica and Parinacota, and Coquimbo. Since 1999 it is considered that in Chile ...